Application 204403
- Type
- ANDA
- Sponsor
- ALVOGEN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | RIVASTIGMINE | RIVASTIGMINE | FILM, EXTENDED RELEASE;TRANSDERMAL | 4.6MG/24HR | No | No |
| 002 | RIVASTIGMINE | RIVASTIGMINE | FILM, EXTENDED RELEASE;TRANSDERMAL | 9.5MG/24HR | No | No |
| 003 | RIVASTIGMINE | RIVASTIGMINE | FILM, EXTENDED RELEASE;TRANSDERMAL | 13.3MG/24HR | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A204403-001 | RIVASTIGMINE | RIVASTIGMINE | 4.6MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2015-09-03 | ||
| A204403-002 | RIVASTIGMINE | RIVASTIGMINE | 9.5MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2015-09-03 | ||
| A204403-003 | RIVASTIGMINE | RIVASTIGMINE | 13.3MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2015-08-31 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A204403-001 | RIVASTIGMINE | 4.6MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2015-09-03 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A204403-002 | RIVASTIGMINE | 9.5MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2015-09-03 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A204403-003 | RIVASTIGMINE | 13.3MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2015-08-31 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A204403-001 | RIVASTIGMINE | 4.6MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2015-09-03 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A204403-002 | RIVASTIGMINE | 9.5MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2015-09-03 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A204403-003 | RIVASTIGMINE | 13.3MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2015-08-31 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204403-001 | RIVASTIGMINE | 4.6MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2015-09-03 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204403-002 | RIVASTIGMINE | 9.5MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2015-09-03 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204403-003 | RIVASTIGMINE | 13.3MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2015-08-31 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A204403-001 | RIVASTIGMINE | 4.6MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2015-09-03 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A204403-002 | RIVASTIGMINE | 9.5MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2015-09-03 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A204403-003 | RIVASTIGMINE | 13.3MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | 2015-08-31 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204403-001 | RIVASTIGMINE | 4.6MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | AB | 2015-09-03 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204403-002 | RIVASTIGMINE | 9.5MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | AB | 2015-09-03 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204403-003 | RIVASTIGMINE | 13.3MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | AB | 2015-08-31 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204403-001 | RIVASTIGMINE | 4.6MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | AB | 2015-09-03 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204403-002 | RIVASTIGMINE | 9.5MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | AB | 2015-09-03 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204403-003 | RIVASTIGMINE | 13.3MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | AB | 2015-08-31 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A204403-001 | RIVASTIGMINE | 4.6MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | AB | 2015-09-03 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A204403-002 | RIVASTIGMINE | 9.5MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | AB | 2015-09-03 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A204403-003 | RIVASTIGMINE | 13.3MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | AB | 2015-08-31 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A204403-001 | RIVASTIGMINE | 4.6MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | AB | 2015-09-03 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A204403-002 | RIVASTIGMINE | 9.5MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | AB | 2015-09-03 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A204403-003 | RIVASTIGMINE | 13.3MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | AB | 2015-08-31 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A204403-001 | RIVASTIGMINE | 4.6MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | AB | 2015-09-03 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A204403-002 | RIVASTIGMINE | 9.5MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | AB | 2015-09-03 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A204403-003 | RIVASTIGMINE | 13.3MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | AB | 2015-08-31 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A204403-001 | RIVASTIGMINE | 4.6MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | AB | 2015-09-03 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A204403-002 | RIVASTIGMINE | 9.5MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | AB | 2015-09-03 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A204403-003 | RIVASTIGMINE | 13.3MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | AB | 2015-08-31 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A204403-001 | RIVASTIGMINE | 4.6MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | AB | 2015-09-03 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A204403-002 | RIVASTIGMINE | 9.5MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | AB | 2015-09-03 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A204403-003 | RIVASTIGMINE | 13.3MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | AB | 2015-08-31 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A204403-001 | RIVASTIGMINE | 4.6MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | AB | 2015-09-03 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A204403-002 | RIVASTIGMINE | 9.5MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | AB | 2015-09-03 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A204403-003 | RIVASTIGMINE | 13.3MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | AB | 2015-08-31 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A204403-001 | RIVASTIGMINE | 4.6MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | AB | 2015-09-03 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A204403-002 | RIVASTIGMINE | 9.5MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | AB | 2015-09-03 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A204403-003 | RIVASTIGMINE | 13.3MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | AB | 2015-08-31 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A204403-001 | RIVASTIGMINE | 4.6MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | AB | 2015-09-03 | 1e350fbaab3a… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204403-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204403-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204403-003 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204403-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204403-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204403-003 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A204403-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A204403-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A204403-003 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A204403-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A204403-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A204403-003 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A204403-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A204403-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A204403-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A204403-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A204403-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A204403-003 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A204403-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A204403-002 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A204403-003 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A204403-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A204403-002 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A204403-003 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A204403-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A204403-002 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A204403-003 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A204403-001 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A204403-002 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A204403-003 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A204403-001 | AB | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A204403-002 | AB | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A204403-003 | AB | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A204403-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A204403-002 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A204403-003 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A204403-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A204403-002 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A204403-003 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A204403-001 | AB | 1 | 4b0b4de00fa7… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Rivastigmine | RIVASTIGMINE | Zydus Lifesciences Limited | 966d59ea-5cea-4fef-8b96-e0efe885caf4 | 2025-11-17 | Rivastigmine RIVASTIGMINE | |
| Rivastigmine | RIVASTIGMINE | Northstar Rx LLC. | 8b809739-8381-4cc1-ab4a-5b17ab902a3d | 2025-11-14 | Warnings, Adverse reactions | Rivastigmine RIVASTIGMINE |
| Rivastigmine Transdermal System | RIVASTIGMINE | Bryant Ranch Prepack | 8d8823c0-9339-4ec8-8a19-d13974b6614b | 2025-04-01 | Warnings, Adverse reactions | RIVASTIGMINE |
| Rivastigmine Transdermal System | RIVASTIGMINE | Bryant Ranch Prepack | a7f9328e-b6da-4474-ac93-3cdd4825e163 | 2025-04-01 | Warnings, Adverse reactions | RIVASTIGMINE |
| Rivastigmine Transdermal System | RIVASTIGMINE | Bryant Ranch Prepack | 5cd5c434-ffd0-4aed-9eba-145c86b115bb | 2025-03-27 | Warnings, Adverse reactions | RIVASTIGMINE |
| Rivastigmine Transdermal System | RIVASTIGMINE | Bryant Ranch Prepack | a68d70c9-19f2-47db-bf78-4da04a87a702 | 2025-03-20 | Warnings, Adverse reactions | RIVASTIGMINE |
| Rivastigmine Transdermal System | RIVASTIGMINE | Bryant Ranch Prepack | 6cc286d9-c5d4-4505-83bb-9015e3077851 | 2025-03-19 | Warnings, Adverse reactions | RIVASTIGMINE |
| Rivastigmine Transdermal System | RIVASTIGMINE | Breckenridge Pharmaceutical, Inc. | b201fe68-b5e5-4a6f-8cf1-069543f03e76 | 2025-01-15 | Warnings, Adverse reactions | RIVASTIGMINE |
| Rivastigmine Transdermal System | RIVASTIGMINE | Bryant Ranch Prepack | 1ebeb8ec-5348-4bb1-ab3d-834690351094 | 2024-12-24 | Warnings, Adverse reactions | RIVASTIGMINE |
| Rivastigmine | RIVASTIGMINE | Mylan Pharmaceuticals Inc. | 4ab335d1-19ee-4cd9-9776-8086645d19e4 | 2024-09-21 | Warnings, Adverse reactions | Rivastigmine RIVASTIGMINE |
| Rivastigmine Transdermal System | RIVASTIGMINE | Bryant Ranch Prepack | 82630f84-fb47-47ab-8ee2-1720a486de02 | 2024-08-19 | Warnings, Adverse reactions | RIVASTIGMINE |
| Rivastigmine | RIVASTIGMINE | Amneal Pharmaceuticals LLC | 8b671fc9-8cb0-4406-a9ee-7c95086d6200 | 2024-07-02 | Warnings, Adverse reactions | Rivastigmine RIVASTIGMINE |
| Rivastigmine Transdermal System | RIVASTIGMINE | Bryant Ranch Prepack | c569f760-f311-42ba-909c-a36319622b35 | 2024-05-30 | Warnings, Adverse reactions | RIVASTIGMINE |
| Rivastigmine | RIVASTIGMINE | Zydus Pharmaceuticals USA Inc. | 64dad603-2389-456b-8c18-d1d40b7e7419 | 2024-05-27 | Warnings, Adverse reactions | Rivastigmine RIVASTIGMINE |
| Rivastigmine | RIVASTIGMINE | Sandoz Inc | 92a58ebb-748d-49f4-bf11-ecbcf5424152 | 2024-05-08 | Warnings, Adverse reactions | Rivastigmine RIVASTIGMINE |
| Exelon | RIVASTIGMINE | Novartis Pharmaceuticals Corporation | 07c12e14-bbd5-4ec8-84e4-fbe7b5ba10e0 | 2024-05-08 | Warnings, Adverse reactions | RIVASTIGMINE |
| Exelon | RIVASTIGMINE | Sandoz Inc | b6ed6d15-116d-4596-92ce-3414574d7ba0 | 2024-05-08 | Warnings, Adverse reactions | RIVASTIGMINE |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 47781-304 | Rivastigmine Transdermal System | Rivastigmine Transdermal System | Alvogen Inc. | ANDA | Current |
| 47781-304 | Rivastigmine Transdermal System | Rivastigmine Transdermal System | Alvogen Inc. | ANDA | Current |
| 47781-304 | Rivastigmine Transdermal System | Rivastigmine Transdermal System | Alvogen Inc. | ANDA | Current |
| 47781-304 | Rivastigmine Transdermal System | Rivastigmine Transdermal System | Alvogen Inc. | ANDA | Current |
| 47781-304 | Rivastigmine Transdermal System | Rivastigmine Transdermal System | Alvogen Inc. | ANDA | Current |
| 47781-305 | Rivastigmine Transdermal System | Rivastigmine Transdermal System | Alvogen Inc. | ANDA | Current |
| 47781-305 | Rivastigmine Transdermal System | Rivastigmine Transdermal System | Alvogen Inc. | ANDA | Current |
| 47781-305 | Rivastigmine Transdermal System | Rivastigmine Transdermal System | Alvogen Inc. | ANDA | Current |
| 47781-305 | Rivastigmine Transdermal System | Rivastigmine Transdermal System | Alvogen Inc. | ANDA | Current |
| 47781-305 | Rivastigmine Transdermal System | Rivastigmine Transdermal System | Alvogen Inc. | ANDA | Current |
| 47781-405 | Rivastigmine Transdermal System | Rivastigmine Transdermal System | Alvogen Inc. | ANDA | Current |
| 47781-405 | Rivastigmine Transdermal System | Rivastigmine Transdermal System | Alvogen Inc. | ANDA | Current |
| 47781-405 | Rivastigmine Transdermal System | Rivastigmine Transdermal System | Alvogen Inc. | ANDA | Current |
| 47781-405 | Rivastigmine Transdermal System | Rivastigmine Transdermal System | Alvogen Inc. | ANDA | Current |
| 47781-405 | Rivastigmine Transdermal System | Rivastigmine Transdermal System | Alvogen Inc. | ANDA | Current |